Related by context. All words. (Click for frequent words.) 58 Dr. McHutchison 58 YONDELIS R 57 lenalidomide Revlimid 57 Belldegrun 56 thalidomide Thalomid 56 Relling 56 SNT-MC#/idebenone 56 immune modulating 56 Aplidin 56 sargramostim 56 metastatic gastric 56 Sudhir Agrawal D.Phil 56 Iris Loew Friedrich 56 BioNumerik 56 idiopathic thrombocytopenic purpura 56 Myelodysplastic Syndrome 55 Chronic lymphocytic leukemia 55 Kantarjian 55 Liprotamase 55 myeloproliferative neoplasms 55 lymphomas leukemias 55 RhuDex TM 55 Bengt Winblad 55 myeloproliferative disorders 55 relapsed leukemia 55 Mayo Clinic hematologist 55 cholangiocarcinoma 55 galantamine 54 malignant lymphomas 54 Cloretazine 54 Onconase 54 Evoltra ® 54 RhuDex 54 DFMO 54 Arranon 54 EndoTAGTM 1 54 Ascherio 54 multi factorial disease 54 OHR/AVR# 54 Myelodysplastic syndromes MDS 54 pulmonary hypertension PH 54 Aflibercept 54 pulmonary fungal infections 54 haematologic malignancies 54 Doxil ® 54 malignant pleural mesothelioma 54 Fabry Disease 54 TRO# 54 lymphoproliferative disorders 54 multikinase inhibitor 54 smoldering myeloma 54 Myelodysplastic Syndrome MDS 54 MGUS 53 Talpaz 53 MELAS 53 Per Olof Wallström 53 Teriflunomide 53 secondary hyperparathyroidism 53 CCR2 53 squamous cell lung cancer 53 myeloproliferative 53 Temsirolimus 53 Nonalcoholic fatty liver 53 adult chronic ITP 53 imatinib resistance 53 Enzastaurin 53 LHRH agonists 53 BCG refractory 53 prucalopride 53 pharmacokinetic interactions 53 hematological malignancy 53 haematological cancers 53 Nexavar sorafenib 53 PARP inhibition 53 tyrosine kinase inhibitors TKIs 53 pemphigus 53 malignant ascites 53 Malignant Melanoma 53 pan HDAC inhibitor 53 IGF 1R inhibitor 53 vidofludimus 53 myeloproliferative diseases 53 Abram Hoffer 53 Aviptadil 53 Xanafide 53 Zarnestra 53 ZACTIMA 53 PKC# 53 Pseudomonas aeruginosa infections 53 LT NS# 53 Azacitidine 53 Ele Ferrannini 53 von Willebrand 53 erythropoietic 53 UPLYSO 52 patientswith 52 Waldenstrom Macroglobulinemia 52 renoprotective 52 Zeuzem 52 Adjuvant therapy 52 Kalantar Zadeh 52 Panzem 52 erlotinib Tarceva 52 Rasagiline 52 Cholangiocarcinoma 52 Nancy Simonian MD 52 benign prostatic hypertrophy BPH 52 Di Bisceglie 52 non hodgkin lymphoma 52 Pemetrexed 52 micafungin 52 Weinstock Guttman 52 pamidronate 52 metastatic bone 52 ximelagatran 52 VEGF inhibitors 52 Tobinick 52 blood clot dissolving 52 recurrent glioblastoma multiforme 52 paraneoplastic 52 Cheson 52 Degarelix 52 colorectal liver metastases 52 Friedreich 52 selective modulator 52 thrombocytopenic 52 multitargeted 52 Acute myeloid leukemia 52 constipation predominant irritable bowel 52 membranous nephropathy 52 relapsed SCLC 52 HeFH 52 papillary renal cell carcinoma 52 FRDA 52 BEXXAR Therapeutic Regimen 52 angiogenesis inhibition 52 Ryuji Ueno 52 NeuroVive 52 IFN beta 52 Cyclosporin 52 Raptiva R 52 Hashimoto thyroiditis 52 sunitinib malate 52 immune thrombocytopenic purpura 52 Hepatotoxicity 52 AChE inhibitors 52 portal vein thrombosis 52 Vidaza azacitidine 52 Dacogen decitabine 52 Weimbs 52 HCV infection 52 ß blockers 52 essential thrombocythemia ET 52 immuno modulatory 52 metastatic neuroendocrine tumors 52 AA Amyloidosis 52 Gheorghiade 52 pancreatic adenocarcinoma 52 GIST tumors 52 tipifarnib 51 Dr. Sosne 51 relapsed ovarian cancer 51 interferon IFN 51 bendamustine 51 Giaccia 51 multimodality therapy 51 Diamyd ® 51 Myelodysplasia 51 fibromyalgia syndrome 51 cytostatic 51 metastatic malignant 51 Lou Gehrigs disease 51 SNT MC# 51 Antisense Pharma 51 potent antiproliferative 51 carcinoid tumors 51 lung fibrosis 51 Braunwald 51 Fludarabine 51 Piccart 51 Factor VIIa 51 Renal Cell Carcinoma RCC 51 INSPIRE Trial Phase III 51 NOMID 51 receptor tyrosine kinase inhibitor 51 Lupus Nephritis 51 ROCKET AF 51 HER2 overexpression 51 RhuDex ® 51 sitaxsentan 51 EoE 51 Arcalyst 51 Creticos 51 selective inhibition 51 CCR1 51 myelofibrosis polycythemia vera 51 Cancidas 51 ankylosing spondylitis AS 51 ATL/TV# 51 MPS VI 51 Steven R. Deitcher 51 Cimzia TM 51 EndoTAG TM -1 51 MabThera Rituxan 51 AFFiRiS 51 A3 adenosine receptor 51 Mitchell Krucoff 51 Glioma 51 hypereosinophilic syndrome 51 receptor inhibitor 51 panobinostat 51 CALGB # [002] 51 Philip Mease 51 humanised monoclonal antibody 51 allogeneic hematopoietic stem cell 51 adalimumab Humira 51 Sol J. Barer 51 indibulin 51 Daclizumab 51 neuroendocrine cancers 51 HBV genotypes 51 anti angiogenic therapy 51 YONDELIS 51 Removab 51 Ulrich Grau Ph.D. 51 gastrointestinal malignancies 51 Refsum 51 Safinamide 51 pulmonary exacerbations 51 Hereditary angioedema 51 abacavir Ziagen 51 antiangiogenesis 51 dopaminergic therapy 51 Barlogie 51 diabetic kidney 51 ara C 51 lumiliximab 51 gene polymorphism 51 HoFH 51 Mechoulam 51 pegylated liposomal doxorubicin 51 axitinib 51 Garcia Manero 51 cardiac insufficiency 51 PEGylated interferon beta 1a 51 EGFR mutation positive 51 eprotirome 51 Cinacalcet HCl 51 Estrogen Receptor 51 ProLindac TM 51 busulfan 51 antithrombotic 51 Aryplase 51 Hurler syndrome 51 antiphospholipid antibodies 51 levocetirizine 51 Myelofibrosis 51 cell lymphoma CTCL 51 pouchitis 51 David Sidransky 51 palifermin 51 chemotherapeutic regimen 51 ADPKD 51 Karolinska Institute Stockholm 51 somatostatin analogs 51 immunomodulatory agents 51 Kinoid 51 Certolizumab pegol 50 Elafin 50 Bresalier 50 von Willebrand disease 50 Velcade bortezomib 50 Rienhoff 50 metastatic carcinoid 50 Myelodysplastic syndrome 50 beta 1a 50 Tarceva erlotinib 50 Richard Schilsky 50 Alemtuzumab 50 DeKosky 50 HLA DRB1 * 50 Carmeliet 50 kidney urologic 50 GW# [003] 50 metastatic hormone refractory 50 SYN# 50 Severe Asthma 50 tarenflurbil 50 Paavonen 50 HIV HCV coinfected 50 Matthew Meyerson 50 Cristofanilli 50 MPGN 50 pancreatic islet cell 50 Hans Clevers 50 malignant pleural effusion 50 beta interferons 50 Chang Ahn Rexahn 50 DrugResearcher.com 50 cardioprotective effects 50 Hemophilia B 50 Klinikum Grosshadern 50 pancreatic insufficiency 50 sunitinib Sutent 50 gastric lymphoma 50 antiproliferative effects 50 NOD mouse 50 T#I [002] 50 valvular heart 50 leukemia AML 50 Michelakis 50 SUTENT ® 50 Kemal Malik 50 chronic idiopathic thrombocytopenic purpura 50 N. Engl 50 cardiometabolic disorders 50 heterozygous FH 50 Mipomersen 50 thiopurine 50 trabectedin 50 murine models 50 Schilsky 50 HBeAg negative chronic hepatitis 50 aripiprazole Abilify 50 Alton Boynton 50 Wischik 50 Valproic acid 50 chimeric monoclonal antibody 50 Lodamin 50 metastatic lung cancer 50 antitumor effect 50 riociguat 50 Eric Van Cutsem 50 Monoclonal antibody 50 idiopathic pulmonary fibrosis IPF 50 MD tells WebMD 50 acadesine 50 EOquin TM 50 COX2 50 cyclophilin inhibitors 50 mRCC 50 antiangiogenic therapy 50 beta secretase inhibitors 50 PROCHYMAL 50 acute myeloid 50 agomelatine 50 efalizumab 50 chemoresistant 50 corticosteroid induced 50 progressive neurodegenerative disorder 50 β blockers 50 SSc 50 Morquio 50 Goldbach Mansky 50 STRIDE PD 50 antiarrhythmic drug 50 Schunkert 50 Bart De Strooper 50 Valdoxan 50 Rolland Yves Mauvernay 50 acute promyelocytic leukemia 50 mGluR4 activation 50 Johan Auwerx 50 zoledronate 50 cardio renal 50 Tacrolimus 50 mediated inhibition 50 Campochiaro 50 baminercept 50 University Hospital Gasthuisberg 50 BCIRG 50 systemic antifungal 50 Etanercept 50 El Deiry 50 sJIA 50 ABL1 50 Falk Pharma 50 methotrexate therapy 50 hepatorenal syndrome 50 Daniel Von Hoff 50 invasive aspergillosis 50 Montalescot 50 potency selectivity 50 metastatic uveal melanoma 50 CEQ# 50 Simulect 50 Ben Slotman 50 Symadex 50 Cancer Immunobiology Center 50 Glioblastoma Multiforme 50 stage IIIB 50 Sapacitabine 50 Chronic Lymphocytic Leukemia CLL 50 leukemia CLL 50 Zheng Cui 50 inhaled liposomal ciprofloxacin 50 Surgical resection 50 CTAP# Capsules 50 inoperable pancreatic cancer 50 cancer mCRC 50 prostate adenocarcinoma 50 Youdim 50 Mayo Clinic rheumatologist 50 Eckard Weber 50 idiopathic myelofibrosis 50 Bicalutamide 50 histone deacetylase HDAC inhibitor 50 vWD 50 Atypical Hemolytic Uremic Syndrome 50 Pulmonary hypertension 50 inhaled AAT 50 Ceflatonin R 50 SWOG 49 inhibiting COX 49 PDE# inhibitors 49 olmesartan 49 induce orthostatic hypotension 49 glutamic acid decarboxylase 49 Interferon Beta 49 atherosclerotic vascular disease 49 REACH Registry 49 advanced hepatocellular carcinoma 49 RAS blockers 49 Kaklamani 49 cutaneous lupus 49 myelofibrosis 49 Breteler 49 antidiabetic 49 Hypoparathyroidism 49 biliary tract cancer 49 eltrombopag 49 Solesta 49 carcinoid syndrome 49 CTEPH 49 mGluR2 NAM 49 tryptase 49 fluconazole resistant 49 vWF 49 radiolabeled TM# 49 uridine triacetate 49 Kantoff 49 NMIBC 49 Soft Tissue Sarcoma 49 thymoma 49 lenalidomide dexamethasone 49 IL# PE#QQR 49 Laheru 49 Thrombocytopenia 49 RhuDex R 49 infliximab etanercept 49 Liver transplantation 49 Losordo 49 depsipeptide 49 Per Olof Andersson 49 Gaucher Disease 49 plasma pharmacokinetics 49 Amrubicin 49 Kowey 49 potent suppressor 49 mitochondrial toxicity 49 Gilles Montalescot 49 carcinoid cancer 49 HIBM 49 Friedreich Ataxia 49 MD hematologist 49 prostate cancer CRPC 49 Rituximab 49 sickle cell hemoglobin 49 primary immunodeficiency 49 antisense inhibitor 49 genetic polymorphism 49 INS# [001] 49 XYOTAX TM 49 malignant pleural mesothelioma MPM 49 Myasthenia gravis 49 Ilaris 49 Marc Weisskopf 49 Enzyme Replacement Therapy 49 Annamycin 49 Dual Antiplatelet Therapy 49 ANTEGREN 49 thrombocytosis 49 virally induced 49 chronic HBV infection 49 beta carotene supplementation 49 Multaq dronedarone 49 Nuvion 49 Medscape Oncology 49 immunotoxin 49 limbic encephalitis 49 sporadic ALS 49 Elitek 49 Mucopolysaccharidosis 49 pT2 49 Sjogren Syndrome 49 vismodegib 49 PEDF 49 Drakeman 49 treating neuropathic pain 49 Zamvil 49 orphan designation 49 etanercept Enbrel 49 IPAH 49 druggable target 49 Interferon beta 49 Dasatinib 49 airway hyperresponsiveness 49 superficial bladder cancer 49 Virulizin R 49 Ziprasidone 49 glatiramer 49 diagnostic biomarker 49 romiplostim 49 metastatic colorectal 49 Mayo Clinic oncologist 49 PF # [002] 49 Erythropoietic 49 atypical Hemolytic Uremic Syndrome 49 Consultant Rheumatologist 49 Irinotecan 49 primary hyperparathyroidism 49 Ruschitzka 49 Yondelis ® 49 pretransplant 49 gemcitabine carboplatin 49 purpura 49 vandetanib 49 Amarenco 49 antiandrogens 49 immunomodulatory therapy 49 Gefitinib 49 Mantzoros 49 peptidic 49 Bronchiectasis 49 alpha1 antitrypsin AAT deficiency 49 intestinal permeability 49 Tavocept 49 metastatic renal cell 49 Hematologic 49 cranial irradiation 49 TNF alpha inhibitors 49 Zebinix R 49 Niemann Pick disease 49 pro angiogenic 49 HCV infected 49 James Manuso 49 immunomodulation 49 VA# [002] 49 Lixivaptan 49 Hervé Hoppenot President 49 SJIA 49 somatostatin 49 mild hepatic impairment 49 posaconazole 49 Juvenile Idiopathic Arthritis JIA 49 Anaplastic 49 George Perros Greystone 49 colorectal carcinoma 49 HNSCC 49 bronchodilatory 49 Orphan Designation 49 autoimmune thyroid 49 osteopontin 49 therapeutic monoclonal antibody 49 Mestinon 49 Idiopathic Pulmonary Fibrosis 49 T2DM 49 prokinetic 49 noscapine 49 familial hypercholesterolemia 49 Gorlin syndrome 49 oesophageal adenocarcinoma 49 Daviglus 49 Wellstat 49 antiarrhythmic 49 Hakon Hakonarson 49 OXIGON TM 49 cardiotoxic 49 induced hepatotoxicity 49 Epratuzumab 49 ProMune 49 retinal vein occlusion 49 immunopathology 49 Kári Stefánsson 49 chronic granulomatous disease 49 CC genotype 49 gastrointestinal stromal tumor GIST 49 RPLS 49 familial ALS 48 polycystin 1 48 tafamidis 48 dyslipidaemia 48 ATIR 48 Bcr Abl mutations 48 Fluvastatin 48 Etminan 48 vitamin D inadequacy 48 relapsed multiple myeloma 48 pharmacologic intervention 48 insulin sensitizing 48 Kevetrin ™ 48 carcinoid 48 Evoltra 48 ibandronate 48 Plachetka 48 corticosteroid dose 48 oropharyngeal candidiasis 48 Gleevec Glivec 48 Alinia 48 Phenoptin 48 NMDA receptor antagonists 48 Pisters 48 psoriasis psoriatic arthritis 48 humanized monoclonal 48 BNC# 48 Mofenson 48 Clusterin 48 Apo2L 48 HER2 positive breast cancer 48 BCNS 48 curative therapy 48 nonsmall cell lung cancer 48 miRs 48 isolated systolic hypertension 48 cangrelor 48 rindopepimut 48 Wiskott Aldrich syndrome 48 prostate cancer CaP 48 Exelixis XL# 48 epithelial tumors 48 BPS IC 48 Karolinska Institute Stockholm Sweden 48 Tomasz Beer 48 Dinarello 48 Capgras 48 MabCampath 48 Dyskinesia 48 multiple myeloma MM 48 BCR ABL inhibitor 48 Acute Renal Failure 48 topically administered 48 rhMBL 48 bortezomib Velcade 48 ropinirole Requip 48 Phenylketonuria PKU 48 obatoclax 48 MD D.Phil 48 Catena ® 48 intracerebral haemorrhage 48 Fingolimod 48 allograft rejection 48 Issels 48 leukemia ALL 48 VAPRISOL 48 arterial calcification 48 neurotrophic 48 anticoagulant therapy 48 anti fibrotic 48 Galantamine 48 HSP# inhibitors 48 Neil Scolding 48 Proxinium TM 48 Aggrastat ® tirofiban hydrochloride 48 refractory NSCLC 48 anagrelide 48 TASQ 48 Fillit 48 pleural mesothelioma 48 MGd 48 AA amyloidosis 48 Aspergillosis 48 Oparil 48 immunotoxins 48 IRESSA 48 Aldosterone 48 gene polymorphisms 48 Medzhitov 48 Chemotherapy induced 48 AAT deficiency 48 primary humoral immunodeficiency 48 Magnesium deficiency 48 COPD exacerbations 48 TASKi3 48 platelet dysfunction 48 fallopian tube carcinoma 48 Deborah Rathjen 48 somatostatin analogues 48 Medscape Neurology 48 experimental allergic encephalomyelitis 48 Janet Daling 48 chronic ITP patients 48 rotigotine transdermal patch 48 Pulmonary arterial hypertension 48 glatiramer acetate GA 48 refractory colorectal cancer 48 POAG 48 anti Parkinsonian 48 Vidofludimus 48 Stefan Zeuzem MD 48 pheochromocytoma 48 thromboembolic events 48 hematologist oncologist 48 coinfected patients 48 colorectal adenocarcinoma 48 Actinic Keratosis 48 Jan Turek Biolex 48 RSR# 48 adrenomedullin 48 DEB# 48 PPARgamma 48 postoperative ileus 48 Cognitive impairment 48 ABCB1 48 amrubicin 48 tocilizumab 48 Celgene Revlimid 48 Trandolapril 48 neuro degenerative disease 48 decitabine 48 postprandial glycemia 48 mycophenolate mofetil 48 Apaziquone 48 angiogenesis inhibitor 48 Shlipak 48 COPAXONE R 48 tipranavir 48 Torisel 48 Progressive Multifocal Leukoencephalopathy 48 Elevated serum 48 gastrointestinal dysfunction 48 InfaCare 48 VaD 48 Ataluren 48 variceal bleeding 48 inflammatory rheumatic 48 Pimavanserin 48 chemopreventive 48 lymphoproliferative disease 48 Pemphigus 48 RNAi therapeutic targeting 48 opioid induced constipation 48 Glypromate 48 Eitan Kerem 48 McVary 48 acute mania 48 Acute Myelogenous Leukemia AML 48 Non Hodgkins lymphoma 48 PPARγ 48 Blobel 48 guanfacine extended release 48 Glioblastoma Multiforme GBM 48 MTP inhibitor 48 Tlsty 48 abiraterone 48 fistulizing Crohn disease 48 underwent liver transplantation 48 ERK signaling 48 neoplastic diseases 48 inducible nitric oxide synthase 48 nonsteroidal 48 Simeonidis 48 resected pancreatic cancer 48 Seliciclib 48 David Schenkein MD 48 prostate cancer HRPC 48 Boden Albala 48 direct thrombin inhibitors 48 essential thrombocythemia 48 CIMZIA R 48 CAMPATH 48 lymphoma CTCL 48 octreotide 48 metastatic bladder 48 basal cell carcinoma BCC 48 Myelodysplastic Syndromes 48 neuroleptic 48 rilonacept 48 Archexin 48 tumor histology 48 metastatic malignant melanoma 48 idiopathic PAH 48 Acute Myeloid Leukaemia AML 48 Von Hoff 48 lymphocyte activation 48 Fibromyalgia syndrome 48 von Mutius 48 Fx #A 48 Acute Myeloid Leukemia 48 HERCEPTIN 48 common hematologic malignancy 48 liver transplant recipients 48 Idiopathic pulmonary fibrosis 48 paricalcitol 48 IGIV 48 Joseph Loscalzo 48 cMET 48 eIF 4E 48 cellular cytotoxicity 48 LUX Lung 48 idiopathic thrombocytopenic purpura ITP 48 comorbid depression 48 antiangiogenic 48 Pierre Cassigneul 48 Zavesca 48 oral FTY# 48 CYP #D# 48 Occlusive Disease 48 vascular thrombosis 48 Papillary 48 Serious Adverse Events 48 diabetic gastroparesis 48 Pischon 48 CIMZIA ™ 48 B2A 48 thrombotic thrombocytopenic purpura 47 clinicopathological 47 chemoprotective 47 Kandzari 47 Li Fraumeni Syndrome 47 Finckh 47 registrational trial 47 Darapladib 47 chronic GVHD 47 lymphocytic leukemia 47 Staphylococcus aureus infections 47 Meydani 47 Chemoprevention 47 autosomal dominant disorder 47 Primary Immunodeficiency 47 homozygous FH 47 GSK# [001] 47 MD PhD Professor 47 Dr. Pasinetti 47 Targretin 47 Harold H. Shlevin 47 Chronic Myeloid Leukemia 47 Romiplostim 47 sodium valproate 47 Cutaneous T 47 HCV replicon 47 ENGAGE AF TIMI 47 Rik J Deitsch 47 receptor blocker 47 CRF antagonists 47 flavopiridol 47 recurrent DVT 47 Idiopathic Pulmonary Fibrosis IPF 47 motilin 47 Diabetic nephropathy 47 Karl Swedberg 47 cardiac glycosides 47 NP2 Enkephalin 47 GISTs 47 QVAR ® 47 Yaffa Beck 47 radioprotective 47 bevacizumab Avastin ® 47 SGPT 47 OPAXIO 47 Strauss Noven 47 hepatic dysfunction 47 Cyclin E 47 cystinosis 47 antithrombotic therapy 47 LCP Tacro TM 47 Pericak Vance 47 polymyalgia rheumatica 47 chronic prostatitis 47 neuroactive 47 Dr. Hyon Choi 47 uricase 47 Anavex #-# 47 pathogenetic mechanisms 47 George Bakris 47 HuMax EGFr 47 RE LY 47 Pedro Lichtinger 47 SGLT 47 Refractory Angina 47 ZOLINZA 47 Systemic Lupus Erythematosus SLE 47 Leber Hereditary Optic Neuropathy 47 HDAC3 47 mesotheliomas 47 Acute Coronary Syndromes ACS 47 BIM #A# 47 Wolfgang Renner 47 CETP inhibition 47 compound AEZS 47 Timo Veromaa 47 Langerhans cell histiocytosis 47 #beta HSD1 47 Androgel R 47 HDL Selective Delipidation 47 Eliezer Zomer Ph.D. 47 Prolor 47 StemEx R 47 Anthony J. Armini 47 Fedson 47 Violari 47 murine model 47 SGS# 47 Neuro Oncology Program 47 Stolzenberg Solomon 47 advanced NSCLC 47 Haim Aviv 47 vasoactive 47 MabThera rituximab 47 Anders Sundstrom 47 clomipramine 47 Renal Anemia 47 Herman Scholtz 47 ASCO GI 47 noninfectious uveitis 47 Familial hypercholesterolemia 47 SHPT 47 Glivec imatinib 47 Pgp 47 azacytidine 47 Cheresh 47 somatostatin analog 47 DOXIL 47 aurora kinase 47 satraplatin Phase 47 benzimidazole 47 Relapsing Remitting Multiple Sclerosis 47 Dr. Roehrborn 47 cyclosporin 47 metabolomic profiles 47 gastric carcinoma 47 Patrik De Haes 47 fetal microchimerism 47 lupus anticoagulant 47 Cancer Res 47 gamma secretase inhibitor 47 cinacalcet HCl 47 hypomethylating agent 47 ToGA 47 Passik 47 George Coukos 47 volociximab 47 Farkouh 47 Onychomycosis 47 FSAD 47 unresectable stage 47 Ian Fentiman 47 Cytochrome P# 47 gallstone disease 47 Gleevec imatinib mesylate 47 van der Lely 47 eflornithine 47 cinacalcet 47 Voreloxin 47 neuroendocrine tumors 47 Natalizumab 47 Aditya Bardia 47 debilitating autoimmune 47 doxorubicin Adriamycin 47 Velculescu 47 Sackner Bernstein 47 hepatic encephalopathy 47 chronic myeloid 47 pentoxifylline 47 Pieter Muntendam 47 ACZ# 47 AZILECT R 47 GRASPA ® 47 treat benign prostatic 47 ISTODAX 47 Val HeFT 47 underlying pathophysiology 47 Sabine Bahn 47 cutaneous T cell 47 dyskinetic 47 Cathepsin S 47 chemoresistance 47 interferon beta therapy 47 AAT Deficiency 47 Grothey 47 antioxidant supplementation 47 Donepezil 47 Amir Lerman 47 MD DPhil 47 relapsed CLL 47 ALI ARDS 47 Subgroup analysis 47 Allergic Rhinitis 47 ertapenem 47 Fintan Walton 47 acetonide FA 47 MD Ph.D. Principal Investigator 47 SIR Spheres 47 teratogenic effects 47 AVONEX ® 47 transthyretin amyloidosis 47 Fred Kavalier 47 T Cell Lymphoma 47 HBeAg negative 47 Somesh Sharma